February 16, 2016
Kite Pharma to Participate in the 2016 RBC Capital Markets Global Healthcare Conference
SANTA MONICA, Calif., Feb. 16, 2016 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE) today announced that David D. Chang, M.D., Ph.D., Executive Vice President, Research and Development, and Chief Medical Officer, will participate in a fireside chat discussion at the 2016 RBC Capital Markets Global Healthcare Conference.
|Event: ||2016 RBC Capital Markets Global Healthcare Conference|
|Date: ||Tuesday, February 23, 2016|
|Time: ||4:05 PM Eastern Time|
|Location: ||New York, NY|
A live audio webcast will be available on the Investors section of Kite's website, www.kitepharma.com. A replay of the webcast will be available on the website for approximately 30 days.
About Kite Pharma
Kite Pharma, Inc.,
is a clinical-stage biopharmaceutical company engaged in the
development of novel cancer immunotherapy products, with a primary focus
on engineered autologous cell therapy (eACT™) designed to restore the
immune system's ability to recognize and eradicate tumors. Kite is based
in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.
CONTACT: Greg Mann
VP, Investor Relations
For Media: Justin JacksonBurns McClellan
Source: Kite Pharma, Inc.
News Provided by Acquire Media